111 Other Long-Term Assets 2018-2024 | YI
111 Annual Other Long-Term Assets (Millions of US $) |
|
---|---|
2024 | $2 |
2023 | $2 |
2022 | $3 |
2021 | $3 |
2020 | $1 |
2019 | $0 |
2018 | $0 |
2017 | $0 |
111 Quarterly Other Long-Term Assets (Millions of US $) |
|
---|---|
2024-12-31 | $2 |
2024-09-30 | $2 |
2024-06-30 | $2 |
2024-03-31 | $2 |
2023-12-31 | $2 |
2023-09-30 | $2 |
2023-06-30 | $3 |
2023-03-31 | $3 |
2022-12-31 | $3 |
2022-09-30 | $3 |
2022-06-30 | $3 |
2022-03-31 | $4 |
2021-12-31 | $3 |
2021-09-30 | $4 |
2021-06-30 | $4 |
2021-03-31 | $2 |
2020-12-31 | $1 |
2020-09-30 | $1 |
2020-06-30 | $0 |
2020-03-31 | $1 |
2019-12-31 | $0 |
2019-09-30 | $1 |
2019-06-30 | $0 |
2019-03-31 | $1 |
2018-09-30 | |
2017-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.068B | $1.973B |
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $38.151B | 48.75 |
Hims & Hers Health (HIMS) | United States | $11.939B | 124.05 |
Tempus AI (TEM) | United States | $9.210B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.513B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.137B | 64.64 |
Privia Health (PRVA) | United States | $2.813B | 192.25 |
Enovis (ENOV) | United States | $1.861B | 10.37 |
Clover Health Investments (CLOV) | United States | $1.593B | 0.00 |
Schrodinger (SDGR) | United States | $1.579B | 0.00 |
Phreesia (PHR) | United States | $1.385B | 0.00 |
Omnicell (OMCL) | United States | $1.376B | 24.27 |
Azenta (AZTA) | United States | $1.241B | 57.66 |
10x Genomics (TXG) | United States | $1.091B | 0.00 |
Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.626B | 0.00 |
Talkspace (TALK) | United States | $0.495B | 148.00 |
Veradigm (MDRX) | United States | $0.460B | 0.00 |
Claritev (CTEV) | United States | $0.438B | 0.00 |
Standard BioTools (LAB) | United States | $0.414B | 0.00 |
TruBridge (TBRG) | United States | $0.358B | 793.33 |
Outset Medical (OM) | United States | $0.346B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
Health Catalyst (HCAT) | United States | $0.256B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.135B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.132B | 0.00 |
Pulmonx (LUNG) | United States | $0.119B | 0.00 |
American Well (AMWL) | United States | $0.109B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
CareCloud (CCLD) | United States | $0.087B | 3.31 |
HeartBeam (BEAT) | United States | $0.054B | 0.00 |
P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
Zhongchao (ZCMD) | China | $0.028B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
Precipio (PRPO) | United States | $0.015B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |